Audientes (AUDNTS) Q4 2024 earnings summary

Executive summary

• Expanded market presence in Japan, China, Europe, India, and the MENA region, launching localized products and building new distribution partnerships.

• Shifted business model to include software platform licensing and established a joint venture in China, reducing working capital needs.

• Focused on self-fitting hearing solutions and expert-assisted products, targeting both OTC and professional channels.

• Introduced new product development, including a Receiver-in-Canal (RIC) hearing aid and localized Companion hearable.

• Capitalization efforts included rights and directed share issues, debt conversions, and ongoing plans for a corporate bond issuance.

Financial highlights

• 2024 revenue was DKK 840,000, below the initial DKK 1.5 million target, with Q4 revenue rising to DKK 540,000.

• EBITDA improved to DKK -5.4 million in 2024 (from DKK -7.3 million in 2023), within guidance.

• Net loss for 2024 was DKK -10.9 million, an improvement from DKK -13.4 million in 2023.

• Equity decreased from DKK 4 million to DKK 1.2 million, with an equity ratio of 13.6%.

• Cash and cash equivalents at year-end were DKK 9,000, down from DKK 434,000 in 2023.

Outlook and guidance

• Expects significant revenue growth in 2025, driven by expanded market presence, product sales, licensing, and product creation services.

• Path to profitability targeted for 2026, with break-even operations as a key goal.

• 2025 guidance to be provided after further solidifying assumptions and funding plans.